Monday, July 20, 2009

FDA Guidance on ANDA Drug Impurities

Updated October 11, 2020

The original link broke.

You might also be interested in:

- - -  original post follows below  - - -

This guidance, FDA Guidance - ANDAs: Impurities in Drug Substances, provides revised recommendations on what chemistry, manufacturing, and controls (CMC) information to include regarding the reporting, identification, and qualification of impurities in drug substances produced by chemical synthesis when submitting: 1) Original abbreviated new drug applications (ANDAs), 2) Drug master files (DMFs) including type II DMFs, and 3) ANDA supplements for changes in the synthesis or processing of a drug substance.

Return Home: http://drughealth.blogspot.com/ 

----------

FDA cGMP QSR GMP Training - online training courses by SkillsPlus International Inc.

FDA cGMP QSR GMP Training - online training courses by SkillsPlus International Inc.


SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

No comments:

From SkillsPlus International Inc.